Acute Respiratory Distress Syndrome: Gaps and Knowledge of the Clinical Approach
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Pulmonary".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 95
Special Issue Editor
Special Issue Information
Dear colleagues,
In this Special Issue regarding acute respiratory distress syndrome (ARDS), many fields are covered, with the aim of clarifying the following: I) epidemiology (incidence, management outcomes, mortality), ii) pathophysiology, iii) diagnosis considerations, iv) recent notions on clinical management, and v) new treatments such as mesenchymal stem cells that highlight the new phenotypes of ARDS. The causes of ARDS are multifactorial, and the most common are sepsis, bacterial and viral pneumonia, aspiration pneumonia, pancreatitis, serious trauma, and drug overdose. However, the diagnostic and therapeutic criteria are not well defined and are still debated. This Special Issue reports the fundamentals of mechanical ventilation, neuromuscular blockade, pharmacological management, and possible post-ARDS complications such as multi-organ failure, pneumothorax, pulmonary fibrosis, and ventilator-associated pneumonia. It also considers the commonalities between ARDS and COVID-19 and their relative distinctions with COVID-19 which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), including well-researched clinical trials.
In summary, this Special Issue improves the clinical approach of ARDS by highlighting controversies and new research on various topics, reducing gaps by improving the knowledge of clinical characteristics and pathological mechanisms and suggesting future options.
Prof. Dr. Roberto G. Carbone
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- acute respiratory distress syndrome (ARDS)
- COVID-19
- epidemiology
- cause and risk factor
- clinical management
- treatment
- outcome
- mortality
